CYCN - Cyclerion Therapeutics in compliance with Nasdaq minimum bid price rule
2023-06-01 16:40:27 ET
- Cyclerion Therapeutics ( NASDAQ: CYCN ) has received a formal notice from The Nasdaq stating that it has regained compliance with the $1/share minimum bid price requirement pursuant to Nasdaq Listing Rule.
- In order to regain compliance, the Co. was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days.
- This requirement was met on May 30, 2023, the tenth consecutive trading day when the closing bid price.
- CYCN +5.75% after hours to $4.60.
For further details see:
Cyclerion Therapeutics in compliance with Nasdaq minimum bid price rule